<DOC>
	<DOCNO>NCT00873535</DOCNO>
	<brief_summary>Alcohol nicotine dependence often co-morbid , 85 % alcoholic also smoke . However , little research conduct nature co-occurrence . Thus , main aim study ass difference alcohol tobacco consumption cue-induced crave treatment-seeking smoker two week treatment varenicline . Hypotheses 1 . Two week varenicline treatment significantly decrease cue-induced tobacco craving compare placebo ( Due action varenicline alpha-4-beta-2 receptor downstream effect dopamine release ) . 2 . Varenicline decrease cue-induced alcohol craving compare placebo . 3 . The impact Varenicline cue-induced alcohol crave great heavy drinker compare social drinker .</brief_summary>
	<brief_title>Effect Varenicline Reactivity Smoking Drinking Cues</brief_title>
	<detailed_description>The relationship alcohol tobacco dependence need address population generally exclude clinical trial involve smoke cessation pharmacotherapy . Furthermore , effect Varenicline ( Pfizer Pharmaceuticals ) treatment tobacco cue-induced craving empirically measure , effect varenicline alcohol consumption . In addition effective aid smoking cessation , preliminary evidence show Varenicline decrease alcohol consumption animal model . Varenicline partial agonist α4β2 nicotinic acetylcholine receptor . This drug 's partial agonist effect allow activation receptor lesser degree nicotine simultaneously prevent nicotine binding due drug high affinity ( i.e . : antagonist effect ) receptor subtype . Varenicline recently approve Canada aid smoking cessation . This study double-blind , placebo-controlled randomize study . It assess difference alcohol tobacco consumption cue-induced crave treatment-seeking smoker two week treatment either varenicline placebo.Ultimately This study may help understand association smoke drinking alcohol . This study consist two study group compose 40 subject randomize receive either placebo varenicline ( 0.5mg daily day 1-3 , 0.5mg twice daily day 4-7 follow 1mg twice daily day 8-14 ) . One group heavy smoker heavy drinker heavy smoker social drinker . Upon enter study , subject undergo baseline cognitive craving measure tobacco alcohol associate cue presentation prior randomization varenicline placebo . Subjects provide 1-week supply study medication direction use . During period , subject request complete diary outline cigarette alcohol crave consumption day outline adverse effect . Upon completion 1-week period , subject attend Centre Addiction Mental Health ( CAMH ) old pill bottle daily diary collect supply study medication ( 1mg varenicline take twice daily placebo ) daily diary additional week . At visit , subject complete symptom checklist . At end second week treatment , subject request return CAMH crave tobacco alcohol cue-reactivity assess similar manner study day After study completion , subject give option continue varenicline 12-week treatment plan Nicotine Dependence Clinic .</detailed_description>
	<mesh_term>Alcoholism</mesh_term>
	<mesh_term>Tobacco Use Disorder</mesh_term>
	<mesh_term>Ethanol</mesh_term>
	<mesh_term>Nicotine</mesh_term>
	<mesh_term>Varenicline</mesh_term>
	<criteria>Heavy Smokers/Heavy Drinkers Treatment seek smoker Age 18 65 year Smoke ≥ 10 cigarette per day Fagerstrom Test Nicotine Dependence score &gt; 3 Alcohol Use Disorders Identification Test ( AUDIT ) &gt; 8 Drink &gt; 25 drink per week male &gt; 20 drink per week female Able provide write informed consent Inclusion Criteria ( Heavy Smokers/Social Drinkers ) : Treatment seek smoker Age 18 65 year Smoke ≥ 10 cigarette per day Fagerstrom Test Nicotine Dependence score &gt; 3 Alcohol Use Disorders Identification Test ( AUDIT ) &lt; 8 Drink &lt; 14 drink per week male &lt; 9 drink per week female Able provide write informed consent Exclusion Criteria ( Heavy Smokers/Heavy Drinkers ) : Any medical condition require immediate investigation treatment Beck Depression Inventory score &gt; 16 Insulindependent diabetes Drink &gt; 70 standard alcoholic drink per week male drink &gt; 52 standard alcoholic drink per week female Pregnancy lactation Current DSMIV Axis 1 psychiatric disorder Regular use therapeutic recreational psychoactive drug use last three month substance use disorder , exception tobacco alcohol . Exclusion Criteria ( Heavy Smokers/Social Drinkers ) : Any medical condition require immediate investigation treatment Beck Depression Inventory score &gt; 16 Insulindependent diabetes Drink &gt; 14 standard alcoholic drink per week male &gt; 9 standard alcoholic drink per week female Pregnancy lactation Current DSMIV Axis 1 psychiatric disorder Regular use therapeutic recreational psychoactive drug use last three month substance use disorder , exception tobacco .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Nicotine</keyword>
	<keyword>Nicotine dependence</keyword>
	<keyword>Smoking cessation</keyword>
	<keyword>Alcohol</keyword>
	<keyword>Alcohol dependence</keyword>
	<keyword>Alcohol cessation</keyword>
	<keyword>Treatment</keyword>
	<keyword>Smoking</keyword>
	<keyword>Cigarette</keyword>
	<keyword>Heavy drinker</keyword>
	<keyword>Social drinker</keyword>
	<keyword>Co-morbidity alcohol nicotine dependence</keyword>
	<keyword>Nicotine receptor</keyword>
	<keyword>Nicotinic receptor</keyword>
	<keyword>Nicotinic acetycholine receptor</keyword>
	<keyword>Alpha-4-beta-2 nicotinic acetycholine receptor</keyword>
	<keyword>Cholinergic receptor</keyword>
	<keyword>Dopamine</keyword>
	<keyword>Craving</keyword>
	<keyword>Diary</keyword>
	<keyword>Cue induce</keyword>
	<keyword>Pharmacotherapy</keyword>
	<keyword>Varenicline</keyword>
	<keyword>Chantix</keyword>
	<keyword>Champix</keyword>
</DOC>